Display Settings:

Format
Items per page

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 6

1.

lenalidomide

A thalidomide analog with potential antineoplastic activity. Lenalidomide inhibits TNF-alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis. This agent also promotes G1 cell cycle arrest and apoptosis of malignant cells. [from NCI]

MedGen UID:
218323
Concept ID:
C1144149
Pharmacologic Substance
2.

Malignant tumor of prostate

A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas. -- 2003 [from NCI]

MedGen UID:
138169
Concept ID:
C0376358
Neoplastic Process
3.

Prostate cancer

A cancer of the `prostate` (FMA:9600). [from HPO]

MedGen UID:
506673
Concept ID:
CN167851
Finding
4.

Lenalidomide

MedGen UID:
450014
Concept ID:
CN077539
Pharmacologic Substance
5.

Prostate cancer recurrent

Prostate cancer reemerging after a period of remission. [from NCI]

MedGen UID:
75878
Concept ID:
C0278838
Neoplastic Process
6.

Lenalidomide response

MedGen UID:
450465
Concept ID:
CN077993
Sign or Symptom

Display Settings:

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...